We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IPA Warns U.S. Trade Rep’s Review Could Dampen Investment in India
IPA Warns U.S. Trade Rep’s Review Could Dampen Investment in India
December 16, 2014
An Indian pharma group is warning that continued scrutiny of India’s intellectual property regime by the U.S. Trade Representative could dampen investment in the country.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor